{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:13:02Z","timestamp":1760044382965},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1981,5,1]],"date-time":"1981-05-01T00:00:00Z","timestamp":357523200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1981,5]]},"DOI":"10.1007\/bf00426468","type":"journal-article","created":{"date-parts":[[2004,11,10]],"date-time":"2004-11-10T17:35:13Z","timestamp":1100108113000},"page":"372-375","source":"Crossref","is-referenced-by-count":49,"title":["The stimulus properties of ?-hydroxybutyrate"],"prefix":"10.1007","volume":"73","author":[{"given":"J. C.","family":"Winter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00502071","volume":"279","author":"NE And\u00e9n","year":"1973","unstructured":"And\u00e9n NE, Stock G (1973) Inhibitory effect of ?-hydroxybutyric acid and ?-aminobutyric acid on the dopamine cells in the substantia nigra. Naunyn Schmiedebergs Arch Pharmacol 279:89?92","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0317167100119304","volume":"6","author":"R Broughton","year":"1979","unstructured":"Broughton R, Mamelak M (1979) The treatment of narcolepsy-cataplexy with nocturnal ?-hydroxybutyrate. J Can Sci Neurology 6:1?6","journal-title":"J Can Sci Neurology"},{"key":"CR3","first-page":"130","volume":"207","author":"JD Doherty","year":"1978","unstructured":"Doherty JD, Hattox SE, Snead OC, Roth RH (1978) Identification of endogenous ?-hydroxybutyrate in human and bovine brain. J Pharmacol Exp Ther 207:130?139","journal-title":"J Pharmacol Exp Ther"},{"key":"CR4","volume-title":"Biostatistics","author":"A Goldstein","year":"1964","unstructured":"Goldstein A (1964) Biostatistics. MacMillan, New York London"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0006-2952(70)90251-0","volume":"19","author":"A Guidotti","year":"1970","unstructured":"Guidotti A, Ballotti PL (1970) Relationship between pharmacological effects and blood and brain levels of ?-butyrolactone and ?-hydroxybutyrate. Biochem Pharmacol 19:883?894","journal-title":"Biochem Pharmacol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF00401468","volume":"22","author":"ID Hirschhorn","year":"1971","unstructured":"Hirschhorn ID, Winter JC (1971) Mescaline and lysergic acid diethylamide (LSD) as discriminative stimuli. Psychopharmacologia 22:64?71","journal-title":"Psychopharmacologia"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0091-3057(75)90041-6","volume":"3","author":"ID Hirschhorn","year":"1975","unstructured":"Hirschhorn ID, Winter JC (1975) Differences in the stimulus properties of barbital and hallucinogens. Pharmacol Biochem Behav 3:343?347","journal-title":"Pharmacol Biochem Behav"},{"key":"CR8","first-page":"417","volume":"1","author":"JM Jouany","year":"1960","unstructured":"Jouany JM, Gerard J, Broussolle B, Reynier M, Orsetti A, Vermuth C, Baron C (1960) Pharmacologie comparee des sels de l'acide butyrique et de l'acide 4-hydroxybutyrique. Agressologie 1:417?427","journal-title":"Agressologie"},{"key":"CR9","first-page":"397","volume":"1","author":"H Laborit","year":"1960","unstructured":"Laborit H, Jouany JM, Gerard J, Fabiani F (1960) Gen\u00e9ralit\u00e9s concernant l'\u00e9tude experimentale de l'emploi clinique du ?-hydroxybutyrate de Na. Agressologie 1:397?406","journal-title":"Agressologie"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF01250785","volume":"46","author":"S Liljequist","year":"1979","unstructured":"Liljequist S, Engel J (1979) Attenuation of the ?-butyrolactone-induced increase in DOPA accumulation by chronic ethanol administration. J Neural Transm 46:195?204","journal-title":"J Neural Transm"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0014-2999(79)90460-6","volume":"53","author":"HR Olpe","year":"1979","unstructured":"Olpe HR, Koella WP (1979) Inhibition of nigral and neocortical cells by ?-hydroxybutyrate: A microiontophoretic investigation. Eur J Pharmacol 53:359?364","journal-title":"Eur J Pharmacol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/ana.410060206","volume":"6","author":"I Osorio","year":"1979","unstructured":"Osorio I, Davidoff RA (1979) Gamma-hydroxybutyric acid is not a GABA-mimetic agent in the spinal cord. Ann Neurol 6:111?116","journal-title":"Ann Neurol"},{"key":"CR13","first-page":"3297","volume":"38","author":"PA Palumbo","year":"1979","unstructured":"Palumbo PA, Winter JC (1979) Discriminative stimulus properties of morphine, ketocyclazocine, and SKF 10047. Fed Proc 38:3297","journal-title":"Fed Proc"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0006-2952(69)90032-X","volume":"18","author":"RH Roth","year":"1969","unstructured":"Roth RH, Giarman NJ (1969) In vivo conversion of ?-aminobutyric acid to ?-hydroxybutyric acid in the rat. Biochem Pharmacol 18:247?250","journal-title":"Biochem Pharmacol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/0006-2952(70)90370-9","volume":"19","author":"RH Roth","year":"1970","unstructured":"Roth RH, Giarman JJ (1970) Natural occurrence of ?-hydroxybutyrate in mammalian brain. Biochem Pharmacol 19:1087?1093","journal-title":"Biochem Pharmacol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1212\/WNL.28.7.636","volume":"28","author":"OC Snead","year":"1978","unstructured":"Snead OC (1978) ?-Hydroxybutyrate in the monkey I. Electroencephalographic, behavioral, and pharmacokinetic studies. Neurology 28:636?648","journal-title":"Neurology"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0301-0082(78)90009-6","volume":"10","author":"IA Sytinsky","year":"1978","unstructured":"Sytinsky IA, Soldatenkov AT, Lajtha A (1978) Neurochemical basis of the therapeutic effect of ?-aminobutyric acid and its derivatives. Prog Neurobiol 10:89?133","journal-title":"Prog Neurobiol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1126\/science.6101294","volume":"207","author":"JF Tallman","year":"1980","unstructured":"Tallman JF, Paul SM, Skolnick P, Gallagher DW (1980) Receptors for the age of anxiety: Pharmacology of the benzodiazepines. Science 207:274?281","journal-title":"Science"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00428896","volume":"44","author":"JC Winter","year":"1975","unstructured":"Winter JC (1975) The stimulus properties of morphine and ethanol. Psychopharmacologia 44:209?214","journal-title":"Psychopharmacologia"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-1-4613-3967-0_4","volume-title":"Contemporary research in behavioral pharmacology","author":"JC Winter","year":"1978","unstructured":"Winter JC (1978) Drug-induced stimulus control. In: Blackman DE, Sanger DJ (eds) Contemporary research in behavioral pharmacology. Plenum, New York, p 209"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/0028-3908(79)90085-6","volume":"18","author":"WD Winters","year":"1979","unstructured":"Winters WD, Kott KS (1979) Continuum of sedation, activation, and hypnosis or hallucinosis: A comparison of low-dose effects of pentobarbital diazepam, of ?-hydroxybutyrate in the cat. Neuropharmacology 18:877?884","journal-title":"Neuropharmacology"},{"key":"CR22","first-page":"193","volume-title":"Psychotomimetic drugs","author":"WD Winters","year":"1970","unstructured":"Winters WD, Wallach MB (1970) Drug-induced states of CNS excitation: A theory of hallucinosis. In: Efron DH (ed) Psychotomimetic drugs. Raven, New York, pp 193?214"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00426468.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00426468\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00426468","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T23:32:14Z","timestamp":1554852734000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00426468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,5]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1981,5]]}},"alternative-id":["BF00426468"],"URL":"https:\/\/doi.org\/10.1007\/bf00426468","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981,5]]}}}